The case surrounding Wockhardt’s’ codeine creation practices has ignited a considerable controversy. Reports surfaced suggesting possible data manipulation and insufficient oversight regarding the substance's fabrication. This led to regulatory scrutiny from the United States FDA, culminating in sales bans and sparking serious questions about s… Read More